Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA (2024) Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide
The ability to help a significant proportion of patients with T2D achieve normoglycemia without an increased risk of hypoglycemia represents a paradigm shift, moving the therapeutic goal from mere control towards potential disease remission
Blood 84, 1697
Filtering the solution can help remove aggregated particles and improve overall peptide solubility
Con el tiempo, los profesionales mdicos observaron que quienes usaban este medicamento a menudo reportaban una disminucin del apetito
Any change on the scale reflects the full plan, not the injection alone